Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Top Cited Papers
Open Access
- 1 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 57 (1), 84-91
- https://doi.org/10.1373/clinchem.2010.151845
Abstract
BACKGROUND: MicroRNAs (miRs) are a class of small noncoding RNAs whose expression changes have been associated with cancer development and progression. Current techniques to isolate miRs for expression analysis from blood are inefficient. We developed a reverse-transcription quantitative real-time PCR (RT-qPCR) assay for direct detection of circulating miRs in serum. We hypothesized that serum concentrations of miR-21, a biomarker increased in breast tumors, would correlate with the presence and extent of breast cancer. METHODS: The RT-qPCR applied directly in serum (RT-qPCR-DS) assay for circulating miR-21 was tested in sera from 102 patients with different stages of breast cancer and 20 healthy female donors. RESULTS: The assay was sensitive for detection of miR-21 in 0.625 μL of serum from breast cancer patients. For differentiation of samples from patients with locoregional breast cancer from those from healthy donors, the odds ratio was 1.796 and the area under the curve was 0.721. In a multivariate analysis that included standard clinicopathologic prognostic factors, high circulating miR-21 concentrations correlated significantly (P < 0.001) with visceral metastasis. CONCLUSIONS: A novel RT-qPCR-DS can improve the efficiency of miR assessment. Use of this assay to detect circulating miR-21 has diagnostic and prognostic potential in breast cancer.Keywords
Funding Information
- Leslie and Susan Gonda (Goldschmied) Foundation
- Weil Family Foundation
- ABC Foundation
- California Breast Cancer Research Program (16IB-0076)
This publication has 32 references indexed in Scilit:
- MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosisRNA, 2008
- Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer CellsOnline Journal of Public Health Informatics, 2008
- MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)Journal of Biological Chemistry, 2007
- Mammographic Density and the Risk and Detection of Breast CancerThe New England Journal of Medicine, 2007
- Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trialThe Lancet, 2006
- miR-21-mediated tumor growthOncogene, 2006
- microPrimer: the biogenesis and function of microRNADevelopment, 2005
- The functions of animal microRNAsNature, 2004
- Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiationGenome Biology, 2004
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004